nodes	percent_of_prediction	percent_of_DWPC	metapath
Rufinamide—CYP2E1—Pilocarpine—glaucoma	0.166	0.338	CbGbCtD
Rufinamide—CYP2E1—Methazolamide—glaucoma	0.112	0.228	CbGbCtD
Rufinamide—CYP3A4—Pilocarpine—glaucoma	0.0504	0.102	CbGbCtD
Rufinamide—CYP3A4—Brinzolamide—glaucoma	0.0395	0.0803	CbGbCtD
Rufinamide—CYP3A4—Dorzolamide—glaucoma	0.0382	0.0775	CbGbCtD
Rufinamide—CYP3A4—Methazolamide—glaucoma	0.034	0.0691	CbGbCtD
Rufinamide—CYP3A4—Acetazolamide—glaucoma	0.0272	0.0552	CbGbCtD
Rufinamide—CYP3A4—Clonidine—glaucoma	0.0246	0.05	CbGbCtD
Rufinamide—Rash—Carbachol—glaucoma	0.000844	0.00182	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Apraclonidine—glaucoma	0.000844	0.00182	CcSEcCtD
Rufinamide—Dermatitis—Carbachol—glaucoma	0.000843	0.00182	CcSEcCtD
Rufinamide—Fatigue—Apraclonidine—glaucoma	0.000843	0.00181	CcSEcCtD
Rufinamide—Somnolence—Bimatoprost—glaucoma	0.000842	0.00181	CcSEcCtD
Rufinamide—Headache—Carbachol—glaucoma	0.000839	0.00181	CcSEcCtD
Rufinamide—Weight decreased—Betaxolol—glaucoma	0.000837	0.0018	CcSEcCtD
Rufinamide—Constipation—Apraclonidine—glaucoma	0.000836	0.0018	CcSEcCtD
Rufinamide—Dyspepsia—Bimatoprost—glaucoma	0.000834	0.0018	CcSEcCtD
Rufinamide—Infection—Brimonidine—glaucoma	0.000833	0.00179	CcSEcCtD
Rufinamide—Anxiety—Dorzolamide—glaucoma	0.000833	0.00179	CcSEcCtD
Rufinamide—Leukopenia—Pilocarpine—glaucoma	0.00083	0.00179	CcSEcCtD
Rufinamide—Pneumonia—Betaxolol—glaucoma	0.00083	0.00179	CcSEcCtD
Rufinamide—Anxiety—Travoprost—glaucoma	0.000829	0.00179	CcSEcCtD
Rufinamide—Nausea—Carteolol—glaucoma	0.000829	0.00178	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Travoprost—glaucoma	0.000826	0.00178	CcSEcCtD
Rufinamide—Headache—Levobunolol—glaucoma	0.000826	0.00178	CcSEcCtD
Rufinamide—Infestation NOS—Betaxolol—glaucoma	0.000825	0.00178	CcSEcCtD
Rufinamide—Infestation—Betaxolol—glaucoma	0.000825	0.00178	CcSEcCtD
Rufinamide—Nervous system disorder—Brimonidine—glaucoma	0.000823	0.00177	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Bimatoprost—glaucoma	0.000818	0.00176	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	0.000816	0.00176	CcSEcCtD
Rufinamide—Skin disorder—Brimonidine—glaucoma	0.000815	0.00175	CcSEcCtD
Rufinamide—Nausea—Diclofenamide—glaucoma	0.000815	0.00175	CcSEcCtD
Rufinamide—Dizziness—Latanoprost—glaucoma	0.000808	0.00174	CcSEcCtD
Rufinamide—Vomiting—Methazolamide—glaucoma	0.000803	0.00173	CcSEcCtD
Rufinamide—Abdominal pain upper—Timolol—glaucoma	0.000799	0.00172	CcSEcCtD
Rufinamide—Rash—Methazolamide—glaucoma	0.000796	0.00171	CcSEcCtD
Rufinamide—Dermatitis—Methazolamide—glaucoma	0.000795	0.00171	CcSEcCtD
Rufinamide—Eye disorder—Clonidine—glaucoma	0.000795	0.00171	CcSEcCtD
Rufinamide—Nausea—Carbachol—glaucoma	0.000795	0.00171	CcSEcCtD
Rufinamide—Infection—Travoprost—glaucoma	0.000793	0.00171	CcSEcCtD
Rufinamide—Headache—Methazolamide—glaucoma	0.000791	0.0017	CcSEcCtD
Rufinamide—Breast disorder—Timolol—glaucoma	0.000791	0.0017	CcSEcCtD
Rufinamide—Cardiac disorder—Clonidine—glaucoma	0.00079	0.0017	CcSEcCtD
Rufinamide—Anxiety—Pilocarpine—glaucoma	0.000787	0.00169	CcSEcCtD
Rufinamide—Nausea—Levobunolol—glaucoma	0.000783	0.00169	CcSEcCtD
Rufinamide—Infection—Brinzolamide—glaucoma	0.000783	0.00169	CcSEcCtD
Rufinamide—Nervous system disorder—Travoprost—glaucoma	0.000782	0.00168	CcSEcCtD
Rufinamide—Nasopharyngitis—Timolol—glaucoma	0.000782	0.00168	CcSEcCtD
Rufinamide—Epistaxis—Betaxolol—glaucoma	0.000778	0.00168	CcSEcCtD
Rufinamide—Somnolence—Acetazolamide—glaucoma	0.000777	0.00167	CcSEcCtD
Rufinamide—Skin disorder—Travoprost—glaucoma	0.000775	0.00167	CcSEcCtD
Rufinamide—Sinusitis—Betaxolol—glaucoma	0.000774	0.00167	CcSEcCtD
Rufinamide—Nervous system disorder—Brinzolamide—glaucoma	0.000772	0.00166	CcSEcCtD
Rufinamide—Rash—Latanoprost—glaucoma	0.000771	0.00166	CcSEcCtD
Rufinamide—Dermatitis—Latanoprost—glaucoma	0.00077	0.00166	CcSEcCtD
Rufinamide—Dyspepsia—Acetazolamide—glaucoma	0.000769	0.00166	CcSEcCtD
Rufinamide—Mediastinal disorder—Clonidine—glaucoma	0.000767	0.00165	CcSEcCtD
Rufinamide—Headache—Latanoprost—glaucoma	0.000766	0.00165	CcSEcCtD
Rufinamide—Skin disorder—Brinzolamide—glaucoma	0.000765	0.00165	CcSEcCtD
Rufinamide—Anorexia—Dorzolamide—glaucoma	0.000764	0.00164	CcSEcCtD
Rufinamide—Decreased appetite—Acetazolamide—glaucoma	0.00076	0.00164	CcSEcCtD
Rufinamide—Insomnia—Brimonidine—glaucoma	0.000759	0.00163	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000755	0.00163	CcSEcCtD
Rufinamide—Fatigue—Acetazolamide—glaucoma	0.000754	0.00162	CcSEcCtD
Rufinamide—Infection—Pilocarpine—glaucoma	0.000752	0.00162	CcSEcCtD
Rufinamide—Nausea—Methazolamide—glaucoma	0.00075	0.00162	CcSEcCtD
Rufinamide—Somnolence—Brimonidine—glaucoma	0.000746	0.00161	CcSEcCtD
Rufinamide—Mental disorder—Clonidine—glaucoma	0.000746	0.00161	CcSEcCtD
Rufinamide—Rhinitis—Betaxolol—glaucoma	0.000743	0.0016	CcSEcCtD
Rufinamide—Thrombocytopenia—Pilocarpine—glaucoma	0.000741	0.0016	CcSEcCtD
Rufinamide—Dyspepsia—Brimonidine—glaucoma	0.000739	0.00159	CcSEcCtD
Rufinamide—Insomnia—Dorzolamide—glaucoma	0.000725	0.00156	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Brimonidine—glaucoma	0.000724	0.00156	CcSEcCtD
Rufinamide—Fatigue—Brimonidine—glaucoma	0.000723	0.00156	CcSEcCtD
Rufinamide—Anorexia—Pilocarpine—glaucoma	0.000722	0.00155	CcSEcCtD
Rufinamide—Hypersensitivity—Apraclonidine—glaucoma	0.00072	0.00155	CcSEcCtD
Rufinamide—Insomnia—Brinzolamide—glaucoma	0.000712	0.00153	CcSEcCtD
Rufinamide—Somnolence—Dorzolamide—glaucoma	0.000712	0.00153	CcSEcCtD
Rufinamide—Dysuria—Timolol—glaucoma	0.000707	0.00152	CcSEcCtD
Rufinamide—Dyspepsia—Dorzolamide—glaucoma	0.000705	0.00152	CcSEcCtD
Rufinamide—Dyspepsia—Travoprost—glaucoma	0.000702	0.00151	CcSEcCtD
Rufinamide—Asthenia—Apraclonidine—glaucoma	0.000701	0.00151	CcSEcCtD
Rufinamide—Somnolence—Brinzolamide—glaucoma	0.0007	0.00151	CcSEcCtD
Rufinamide—Vision blurred—Clonidine—glaucoma	0.000698	0.0015	CcSEcCtD
Rufinamide—Decreased appetite—Dorzolamide—glaucoma	0.000697	0.0015	CcSEcCtD
Rufinamide—Tremor—Clonidine—glaucoma	0.000694	0.00149	CcSEcCtD
Rufinamide—Dyspepsia—Brinzolamide—glaucoma	0.000693	0.00149	CcSEcCtD
Rufinamide—Eye disorder—Betaxolol—glaucoma	0.000692	0.00149	CcSEcCtD
Rufinamide—Pruritus—Apraclonidine—glaucoma	0.000691	0.00149	CcSEcCtD
Rufinamide—Fatigue—Dorzolamide—glaucoma	0.000691	0.00149	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Travoprost—glaucoma	0.000689	0.00148	CcSEcCtD
Rufinamide—Fatigue—Travoprost—glaucoma	0.000688	0.00148	CcSEcCtD
Rufinamide—Cardiac disorder—Betaxolol—glaucoma	0.000688	0.00148	CcSEcCtD
Rufinamide—Insomnia—Pilocarpine—glaucoma	0.000685	0.00147	CcSEcCtD
Rufinamide—Decreased appetite—Brinzolamide—glaucoma	0.000685	0.00147	CcSEcCtD
Rufinamide—Weight decreased—Timolol—glaucoma	0.000684	0.00147	CcSEcCtD
Rufinamide—Constipation—Travoprost—glaucoma	0.000682	0.00147	CcSEcCtD
Rufinamide—Agitation—Clonidine—glaucoma	0.000681	0.00147	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Brinzolamide—glaucoma	0.00068	0.00146	CcSEcCtD
Rufinamide—Asthenia—Bimatoprost—glaucoma	0.00068	0.00146	CcSEcCtD
Rufinamide—Fatigue—Brinzolamide—glaucoma	0.000679	0.00146	CcSEcCtD
Rufinamide—Somnolence—Pilocarpine—glaucoma	0.000673	0.00145	CcSEcCtD
Rufinamide—Pruritus—Bimatoprost—glaucoma	0.00067	0.00144	CcSEcCtD
Rufinamide—Immune system disorder—Betaxolol—glaucoma	0.000669	0.00144	CcSEcCtD
Rufinamide—Diarrhoea—Apraclonidine—glaucoma	0.000669	0.00144	CcSEcCtD
Rufinamide—Mediastinal disorder—Betaxolol—glaucoma	0.000668	0.00144	CcSEcCtD
Rufinamide—Dyspepsia—Pilocarpine—glaucoma	0.000666	0.00144	CcSEcCtD
Rufinamide—Decreased appetite—Pilocarpine—glaucoma	0.000658	0.00142	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000654	0.00141	CcSEcCtD
Rufinamide—Mental disorder—Betaxolol—glaucoma	0.000649	0.0014	CcSEcCtD
Rufinamide—Constipation—Pilocarpine—glaucoma	0.000647	0.00139	CcSEcCtD
Rufinamide—Dizziness—Apraclonidine—glaucoma	0.000646	0.00139	CcSEcCtD
Rufinamide—Malnutrition—Betaxolol—glaucoma	0.000645	0.00139	CcSEcCtD
Rufinamide—Epistaxis—Timolol—glaucoma	0.000636	0.00137	CcSEcCtD
Rufinamide—Sinusitis—Timolol—glaucoma	0.000633	0.00136	CcSEcCtD
Rufinamide—Anxiety—Clonidine—glaucoma	0.000629	0.00135	CcSEcCtD
Rufinamide—Asthenia—Acetazolamide—glaucoma	0.000627	0.00135	CcSEcCtD
Rufinamide—Dizziness—Bimatoprost—glaucoma	0.000627	0.00135	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000626	0.00135	CcSEcCtD
Rufinamide—Vomiting—Apraclonidine—glaucoma	0.000621	0.00134	CcSEcCtD
Rufinamide—Hypersensitivity—Brimonidine—glaucoma	0.000618	0.00133	CcSEcCtD
Rufinamide—Dermatitis—Apraclonidine—glaucoma	0.000616	0.00133	CcSEcCtD
Rufinamide—Headache—Apraclonidine—glaucoma	0.000612	0.00132	CcSEcCtD
Rufinamide—Vision blurred—Betaxolol—glaucoma	0.000608	0.00131	CcSEcCtD
Rufinamide—Rhinitis—Timolol—glaucoma	0.000607	0.00131	CcSEcCtD
Rufinamide—Tremor—Betaxolol—glaucoma	0.000604	0.0013	CcSEcCtD
Rufinamide—Asthenia—Brimonidine—glaucoma	0.000602	0.0013	CcSEcCtD
Rufinamide—Infection—Clonidine—glaucoma	0.000601	0.00129	CcSEcCtD
Rufinamide—Diarrhoea—Acetazolamide—glaucoma	0.000598	0.00129	CcSEcCtD
Rufinamide—Rash—Bimatoprost—glaucoma	0.000597	0.00129	CcSEcCtD
Rufinamide—Dermatitis—Bimatoprost—glaucoma	0.000597	0.00129	CcSEcCtD
Rufinamide—Anaemia—Betaxolol—glaucoma	0.000596	0.00128	CcSEcCtD
Rufinamide—Pruritus—Brimonidine—glaucoma	0.000594	0.00128	CcSEcCtD
Rufinamide—Headache—Bimatoprost—glaucoma	0.000594	0.00128	CcSEcCtD
Rufinamide—Nervous system disorder—Clonidine—glaucoma	0.000593	0.00128	CcSEcCtD
Rufinamide—Thrombocytopenia—Clonidine—glaucoma	0.000592	0.00127	CcSEcCtD
Rufinamide—Hypersensitivity—Dorzolamide—glaucoma	0.00059	0.00127	CcSEcCtD
Rufinamide—Hypersensitivity—Travoprost—glaucoma	0.000588	0.00127	CcSEcCtD
Rufinamide—Skin disorder—Clonidine—glaucoma	0.000587	0.00126	CcSEcCtD
Rufinamide—Nausea—Apraclonidine—glaucoma	0.00058	0.00125	CcSEcCtD
Rufinamide—Hypersensitivity—Brinzolamide—glaucoma	0.00058	0.00125	CcSEcCtD
Rufinamide—Vertigo—Betaxolol—glaucoma	0.000579	0.00125	CcSEcCtD
Rufinamide—Dizziness—Acetazolamide—glaucoma	0.000578	0.00124	CcSEcCtD
Rufinamide—Anorexia—Clonidine—glaucoma	0.000576	0.00124	CcSEcCtD
Rufinamide—Asthenia—Dorzolamide—glaucoma	0.000575	0.00124	CcSEcCtD
Rufinamide—Asthenia—Travoprost—glaucoma	0.000572	0.00123	CcSEcCtD
Rufinamide—Pruritus—Dorzolamide—glaucoma	0.000567	0.00122	CcSEcCtD
Rufinamide—Eye disorder—Timolol—glaucoma	0.000566	0.00122	CcSEcCtD
Rufinamide—Asthenia—Brinzolamide—glaucoma	0.000565	0.00122	CcSEcCtD
Rufinamide—Pruritus—Travoprost—glaucoma	0.000564	0.00122	CcSEcCtD
Rufinamide—Nausea—Bimatoprost—glaucoma	0.000563	0.00121	CcSEcCtD
Rufinamide—Cardiac disorder—Timolol—glaucoma	0.000562	0.00121	CcSEcCtD
Rufinamide—Hypersensitivity—Pilocarpine—glaucoma	0.000558	0.0012	CcSEcCtD
Rufinamide—Pruritus—Brinzolamide—glaucoma	0.000557	0.0012	CcSEcCtD
Rufinamide—Vomiting—Acetazolamide—glaucoma	0.000556	0.0012	CcSEcCtD
Rufinamide—Dizziness—Brimonidine—glaucoma	0.000555	0.00119	CcSEcCtD
Rufinamide—Diarrhoea—Dorzolamide—glaucoma	0.000548	0.00118	CcSEcCtD
Rufinamide—Headache—Acetazolamide—glaucoma	0.000548	0.00118	CcSEcCtD
Rufinamide—Anxiety—Betaxolol—glaucoma	0.000547	0.00118	CcSEcCtD
Rufinamide—Insomnia—Clonidine—glaucoma	0.000547	0.00118	CcSEcCtD
Rufinamide—Immune system disorder—Timolol—glaucoma	0.000547	0.00118	CcSEcCtD
Rufinamide—Diarrhoea—Travoprost—glaucoma	0.000546	0.00118	CcSEcCtD
Rufinamide—Mediastinal disorder—Timolol—glaucoma	0.000545	0.00117	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000545	0.00117	CcSEcCtD
Rufinamide—Asthenia—Pilocarpine—glaucoma	0.000543	0.00117	CcSEcCtD
Rufinamide—Diarrhoea—Brinzolamide—glaucoma	0.000539	0.00116	CcSEcCtD
Rufinamide—Somnolence—Clonidine—glaucoma	0.000537	0.00116	CcSEcCtD
Rufinamide—Pruritus—Pilocarpine—glaucoma	0.000536	0.00115	CcSEcCtD
Rufinamide—Mental disorder—Timolol—glaucoma	0.00053	0.00114	CcSEcCtD
Rufinamide—Dizziness—Dorzolamide—glaucoma	0.00053	0.00114	CcSEcCtD
Rufinamide—Rash—Brimonidine—glaucoma	0.000529	0.00114	CcSEcCtD
Rufinamide—Dermatitis—Brimonidine—glaucoma	0.000528	0.00114	CcSEcCtD
Rufinamide—Dizziness—Travoprost—glaucoma	0.000528	0.00114	CcSEcCtD
Rufinamide—Malnutrition—Timolol—glaucoma	0.000527	0.00113	CcSEcCtD
Rufinamide—Headache—Brimonidine—glaucoma	0.000526	0.00113	CcSEcCtD
Rufinamide—Decreased appetite—Clonidine—glaucoma	0.000526	0.00113	CcSEcCtD
Rufinamide—Infection—Betaxolol—glaucoma	0.000523	0.00113	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Clonidine—glaucoma	0.000522	0.00112	CcSEcCtD
Rufinamide—Fatigue—Clonidine—glaucoma	0.000521	0.00112	CcSEcCtD
Rufinamide—Dizziness—Brinzolamide—glaucoma	0.000521	0.00112	CcSEcCtD
Rufinamide—Nausea—Acetazolamide—glaucoma	0.000519	0.00112	CcSEcCtD
Rufinamide—Diarrhoea—Pilocarpine—glaucoma	0.000518	0.00112	CcSEcCtD
Rufinamide—Constipation—Clonidine—glaucoma	0.000517	0.00111	CcSEcCtD
Rufinamide—Nervous system disorder—Betaxolol—glaucoma	0.000516	0.00111	CcSEcCtD
Rufinamide—Thrombocytopenia—Betaxolol—glaucoma	0.000515	0.00111	CcSEcCtD
Rufinamide—Skin disorder—Betaxolol—glaucoma	0.000511	0.0011	CcSEcCtD
Rufinamide—Vomiting—Dorzolamide—glaucoma	0.000509	0.0011	CcSEcCtD
Rufinamide—Rash—Dorzolamide—glaucoma	0.000505	0.00109	CcSEcCtD
Rufinamide—Dermatitis—Dorzolamide—glaucoma	0.000505	0.00109	CcSEcCtD
Rufinamide—Rash—Travoprost—glaucoma	0.000503	0.00108	CcSEcCtD
Rufinamide—Dermatitis—Travoprost—glaucoma	0.000503	0.00108	CcSEcCtD
Rufinamide—Headache—Dorzolamide—glaucoma	0.000502	0.00108	CcSEcCtD
Rufinamide—Anorexia—Betaxolol—glaucoma	0.000502	0.00108	CcSEcCtD
Rufinamide—Vomiting—Brinzolamide—glaucoma	0.000501	0.00108	CcSEcCtD
Rufinamide—Dizziness—Pilocarpine—glaucoma	0.000501	0.00108	CcSEcCtD
Rufinamide—Headache—Travoprost—glaucoma	0.0005	0.00108	CcSEcCtD
Rufinamide—Nausea—Brimonidine—glaucoma	0.000498	0.00107	CcSEcCtD
Rufinamide—Rash—Brinzolamide—glaucoma	0.000497	0.00107	CcSEcCtD
Rufinamide—Vision blurred—Timolol—glaucoma	0.000497	0.00107	CcSEcCtD
Rufinamide—Dermatitis—Brinzolamide—glaucoma	0.000496	0.00107	CcSEcCtD
Rufinamide—Headache—Brinzolamide—glaucoma	0.000493	0.00106	CcSEcCtD
Rufinamide—Vomiting—Pilocarpine—glaucoma	0.000481	0.00104	CcSEcCtD
Rufinamide—Rash—Pilocarpine—glaucoma	0.000477	0.00103	CcSEcCtD
Rufinamide—Dermatitis—Pilocarpine—glaucoma	0.000477	0.00103	CcSEcCtD
Rufinamide—Insomnia—Betaxolol—glaucoma	0.000476	0.00103	CcSEcCtD
Rufinamide—Nausea—Dorzolamide—glaucoma	0.000476	0.00102	CcSEcCtD
Rufinamide—Headache—Pilocarpine—glaucoma	0.000474	0.00102	CcSEcCtD
Rufinamide—Nausea—Travoprost—glaucoma	0.000474	0.00102	CcSEcCtD
Rufinamide—Vertigo—Timolol—glaucoma	0.000473	0.00102	CcSEcCtD
Rufinamide—Nausea—Brinzolamide—glaucoma	0.000468	0.00101	CcSEcCtD
Rufinamide—Dyspepsia—Betaxolol—glaucoma	0.000463	0.000998	CcSEcCtD
Rufinamide—Decreased appetite—Betaxolol—glaucoma	0.000458	0.000985	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Betaxolol—glaucoma	0.000454	0.000979	CcSEcCtD
Rufinamide—Fatigue—Betaxolol—glaucoma	0.000454	0.000977	CcSEcCtD
Rufinamide—Constipation—Betaxolol—glaucoma	0.00045	0.000969	CcSEcCtD
Rufinamide—Nausea—Pilocarpine—glaucoma	0.00045	0.000968	CcSEcCtD
Rufinamide—Anxiety—Timolol—glaucoma	0.000447	0.000963	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000445	0.000959	CcSEcCtD
Rufinamide—Hypersensitivity—Clonidine—glaucoma	0.000445	0.000959	CcSEcCtD
Rufinamide—Asthenia—Clonidine—glaucoma	0.000434	0.000934	CcSEcCtD
Rufinamide—Pruritus—Clonidine—glaucoma	0.000428	0.000921	CcSEcCtD
Rufinamide—Infection—Timolol—glaucoma	0.000427	0.00092	CcSEcCtD
Rufinamide—Nervous system disorder—Timolol—glaucoma	0.000422	0.000908	CcSEcCtD
Rufinamide—Skin disorder—Timolol—glaucoma	0.000418	0.000899	CcSEcCtD
Rufinamide—Diarrhoea—Clonidine—glaucoma	0.000414	0.000891	CcSEcCtD
Rufinamide—Anorexia—Timolol—glaucoma	0.00041	0.000883	CcSEcCtD
Rufinamide—Dizziness—Clonidine—glaucoma	0.0004	0.000861	CcSEcCtD
Rufinamide—Insomnia—Timolol—glaucoma	0.000389	0.000837	CcSEcCtD
Rufinamide—Hypersensitivity—Betaxolol—glaucoma	0.000388	0.000835	CcSEcCtD
Rufinamide—Vomiting—Clonidine—glaucoma	0.000384	0.000828	CcSEcCtD
Rufinamide—Somnolence—Timolol—glaucoma	0.000382	0.000823	CcSEcCtD
Rufinamide—Rash—Clonidine—glaucoma	0.000381	0.000821	CcSEcCtD
Rufinamide—Dermatitis—Clonidine—glaucoma	0.000381	0.00082	CcSEcCtD
Rufinamide—Headache—Clonidine—glaucoma	0.000379	0.000816	CcSEcCtD
Rufinamide—Dyspepsia—Timolol—glaucoma	0.000379	0.000815	CcSEcCtD
Rufinamide—Asthenia—Betaxolol—glaucoma	0.000378	0.000813	CcSEcCtD
Rufinamide—Decreased appetite—Timolol—glaucoma	0.000374	0.000805	CcSEcCtD
Rufinamide—Pruritus—Betaxolol—glaucoma	0.000372	0.000802	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Timolol—glaucoma	0.000371	0.000799	CcSEcCtD
Rufinamide—Fatigue—Timolol—glaucoma	0.000371	0.000798	CcSEcCtD
Rufinamide—Diarrhoea—Betaxolol—glaucoma	0.00036	0.000775	CcSEcCtD
Rufinamide—Nausea—Clonidine—glaucoma	0.000359	0.000773	CcSEcCtD
Rufinamide—Dizziness—Betaxolol—glaucoma	0.000348	0.000749	CcSEcCtD
Rufinamide—Vomiting—Betaxolol—glaucoma	0.000335	0.000721	CcSEcCtD
Rufinamide—Rash—Betaxolol—glaucoma	0.000332	0.000715	CcSEcCtD
Rufinamide—Dermatitis—Betaxolol—glaucoma	0.000332	0.000714	CcSEcCtD
Rufinamide—Headache—Betaxolol—glaucoma	0.00033	0.00071	CcSEcCtD
Rufinamide—Hypersensitivity—Timolol—glaucoma	0.000317	0.000682	CcSEcCtD
Rufinamide—Nausea—Betaxolol—glaucoma	0.000313	0.000673	CcSEcCtD
Rufinamide—Asthenia—Timolol—glaucoma	0.000309	0.000664	CcSEcCtD
Rufinamide—Pruritus—Timolol—glaucoma	0.000304	0.000655	CcSEcCtD
Rufinamide—Diarrhoea—Timolol—glaucoma	0.000294	0.000634	CcSEcCtD
Rufinamide—CES1—E2F transcription factor network—CDKN2A—glaucoma	0.000289	0.00674	CbGpPWpGaD
Rufinamide—Dizziness—Timolol—glaucoma	0.000284	0.000612	CcSEcCtD
Rufinamide—CES1—NRF2 pathway—GSTM1—glaucoma	0.000276	0.00642	CbGpPWpGaD
Rufinamide—Vomiting—Timolol—glaucoma	0.000273	0.000589	CcSEcCtD
Rufinamide—Rash—Timolol—glaucoma	0.000271	0.000584	CcSEcCtD
Rufinamide—Dermatitis—Timolol—glaucoma	0.000271	0.000583	CcSEcCtD
Rufinamide—Headache—Timolol—glaucoma	0.000269	0.00058	CcSEcCtD
Rufinamide—CES1—E2F transcription factor network—CDKN1B—glaucoma	0.000256	0.00597	CbGpPWpGaD
Rufinamide—Nausea—Timolol—glaucoma	0.000255	0.00055	CcSEcCtD
Rufinamide—SCN9A—Developmental Biology—NCK2—glaucoma	0.000249	0.00581	CbGpPWpGaD
Rufinamide—CYP2E1—Tryptophan metabolism—CYP1B1—glaucoma	0.000247	0.00575	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—PAX6—glaucoma	0.000245	0.00571	CbGpPWpGaD
Rufinamide—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	0.000243	0.00566	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—NCK2—glaucoma	0.000238	0.00556	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.000238	0.00554	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—NCK2—glaucoma	0.000229	0.00534	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—NCK2—glaucoma	0.000229	0.00534	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—NCK2—glaucoma	0.000221	0.00515	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—NCK2—glaucoma	0.000221	0.00515	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—PAX6—glaucoma	0.000218	0.00509	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—NCK2—glaucoma	0.000218	0.00507	CbGpPWpGaD
Rufinamide—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.000214	0.005	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—OPN4—glaucoma	0.000207	0.00482	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—TXN—glaucoma	0.000204	0.00476	CbGpPWpGaD
Rufinamide—GRM5—GPCR ligand binding—EDN1—glaucoma	0.000204	0.00476	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—PAX6—glaucoma	0.0002	0.00465	CbGpPWpGaD
Rufinamide—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.0002	0.00465	CbGpPWpGaD
Rufinamide—ALB—Lipid and lipoprotein metabolism—ABCA1—glaucoma	0.000198	0.00463	CbGpPWpGaD
Rufinamide—CYP2E1—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000197	0.00459	CbGpPWpGaD
Rufinamide—ALB—Lipoprotein metabolism—APOE—glaucoma	0.000196	0.00458	CbGpPWpGaD
Rufinamide—ALB—Vitamin B12 Metabolism—ABCA1—glaucoma	0.000195	0.00455	CbGpPWpGaD
Rufinamide—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	0.000194	0.00452	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—HEYL—glaucoma	0.000192	0.00448	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—PTGFR—glaucoma	0.000186	0.00434	CbGpPWpGaD
Rufinamide—GRM5—GPCR ligand binding—C3—glaucoma	0.000178	0.00416	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—BDNF—glaucoma	0.000177	0.00413	CbGpPWpGaD
Rufinamide—ALB—Vitamin B12 Metabolism—SOD1—glaucoma	0.000174	0.00406	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—IL1A—glaucoma	0.00017	0.00397	CbGpPWpGaD
Rufinamide—ALB—FOXA2 and FOXA3 transcription factor networks—NR3C1—glaucoma	0.000163	0.00379	CbGpPWpGaD
Rufinamide—CYP2E1—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000162	0.00377	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—PAX6—glaucoma	0.000161	0.00376	CbGpPWpGaD
Rufinamide—ALB—Platelet degranulation—TGFB2—glaucoma	0.00016	0.00374	CbGpPWpGaD
Rufinamide—ALB—Folate Metabolism—ABCA1—glaucoma	0.000159	0.0037	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—SMO—glaucoma	0.000159	0.0037	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—NGF—glaucoma	0.000157	0.00367	CbGpPWpGaD
Rufinamide—ALB—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000157	0.00365	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.000157	0.00365	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—NCK2—glaucoma	0.000155	0.00362	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—PAX6—glaucoma	0.000154	0.0036	CbGpPWpGaD
Rufinamide—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—glaucoma	0.000153	0.00357	CbGpPWpGaD
Rufinamide—ALB—Response to elevated platelet cytosolic Ca2+—TGFB2—glaucoma	0.000153	0.00356	CbGpPWpGaD
Rufinamide—SCN7A—Axon guidance—MMP2—glaucoma	0.000151	0.00352	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—PAX6—glaucoma	0.000148	0.00346	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—PAX6—glaucoma	0.000148	0.00346	CbGpPWpGaD
Rufinamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000146	0.0034	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—RPTOR—glaucoma	0.000146	0.00339	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—PAX6—glaucoma	0.000143	0.00333	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—PAX6—glaucoma	0.000143	0.00333	CbGpPWpGaD
Rufinamide—ALB—Folate Metabolism—SOD1—glaucoma	0.000142	0.0033	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—NCK2—glaucoma	0.000141	0.00329	CbGpPWpGaD
Rufinamide—ALB—Vitamin B12 Metabolism—MTHFR—glaucoma	0.000138	0.00322	CbGpPWpGaD
Rufinamide—SCN11A—Axon guidance—MMP2—glaucoma	0.000135	0.00314	CbGpPWpGaD
Rufinamide—ALB—Lipid and lipoprotein metabolism—APOE—glaucoma	0.000131	0.00304	CbGpPWpGaD
Rufinamide—ALB—Lipid and lipoprotein metabolism—CAV1—glaucoma	0.000129	0.00301	CbGpPWpGaD
Rufinamide—ALB—Vitamin B12 Metabolism—APOE—glaucoma	0.000128	0.003	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—ABCA1—glaucoma	0.000126	0.00294	CbGpPWpGaD
Rufinamide—SCN8A—Axon guidance—MMP2—glaucoma	0.000123	0.00287	CbGpPWpGaD
Rufinamide—ALB—Platelet degranulation—SOD1—glaucoma	0.000121	0.00283	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—HDAC9—glaucoma	0.00012	0.0028	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—PEX19—glaucoma	0.000118	0.00275	CbGpPWpGaD
Rufinamide—ALB—Response to elevated platelet cytosolic Ca2+—SOD1—glaucoma	0.000116	0.0027	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—EDN1—glaucoma	0.000115	0.00269	CbGpPWpGaD
Rufinamide—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	0.000115	0.00267	CbGpPWpGaD
Rufinamide—SCN7A—Axon guidance—MMP9—glaucoma	0.000114	0.00265	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—SOD1—glaucoma	0.000113	0.00262	CbGpPWpGaD
Rufinamide—ALB—Folate Metabolism—MTHFR—glaucoma	0.000112	0.00262	CbGpPWpGaD
Rufinamide—CYP2E1—Biological oxidations—GSTT1—glaucoma	0.000108	0.00251	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—MMP2—glaucoma	0.000108	0.00251	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—EDN1—glaucoma	0.000105	0.00244	CbGpPWpGaD
Rufinamide—ALB—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000105	0.00244	CbGpPWpGaD
Rufinamide—SCN7A—Axon guidance—VEGFA—glaucoma	0.000102	0.00238	CbGpPWpGaD
Rufinamide—SCN11A—Axon guidance—MMP9—glaucoma	0.000101	0.00236	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—C3—glaucoma	0.000101	0.00235	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—PAX6—glaucoma	0.000101	0.00234	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—MMP2—glaucoma	9.96e-05	0.00232	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—MMP2—glaucoma	9.61e-05	0.00224	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—MMP2—glaucoma	9.53e-05	0.00222	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—SMO—glaucoma	9.38e-05	0.00219	CbGpPWpGaD
Rufinamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	9.26e-05	0.00216	CbGpPWpGaD
Rufinamide—SCN8A—Axon guidance—MMP9—glaucoma	9.26e-05	0.00216	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—MMP2—glaucoma	9.16e-05	0.00213	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—MMP2—glaucoma	9.16e-05	0.00213	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—C3—glaucoma	9.15e-05	0.00213	CbGpPWpGaD
Rufinamide—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	9.14e-05	0.00213	CbGpPWpGaD
Rufinamide—SCN11A—Axon guidance—VEGFA—glaucoma	9.09e-05	0.00212	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—MTHFR—glaucoma	8.92e-05	0.00208	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—MMP2—glaucoma	8.83e-05	0.00206	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—MMP2—glaucoma	8.83e-05	0.00206	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—MMP2—glaucoma	8.79e-05	0.00205	CbGpPWpGaD
Rufinamide—CYP2E1—Biological oxidations—CYP1B1—glaucoma	8.59e-05	0.002	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—NTRK2—glaucoma	8.58e-05	0.002	CbGpPWpGaD
Rufinamide—CYP2E1—Metapathway biotransformation—CYP1B1—glaucoma	8.48e-05	0.00198	CbGpPWpGaD
Rufinamide—ALB—Platelet degranulation—FN1—glaucoma	8.45e-05	0.00197	CbGpPWpGaD
Rufinamide—SCN8A—Axon guidance—VEGFA—glaucoma	8.31e-05	0.00194	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—MMP9—glaucoma	8.11e-05	0.00189	CbGpPWpGaD
Rufinamide—ALB—Response to elevated platelet cytosolic Ca2+—FN1—glaucoma	8.05e-05	0.00188	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—SLC4A4—glaucoma	7.97e-05	0.00186	CbGpPWpGaD
Rufinamide—ALB—SLC-mediated transmembrane transport—SLC6A1—glaucoma	7.66e-05	0.00178	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CA5A—glaucoma	7.56e-05	0.00176	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—NARFL—glaucoma	7.56e-05	0.00176	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—VEGFA—glaucoma	7.52e-05	0.00175	CbGpPWpGaD
Rufinamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	7.51e-05	0.00175	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—MMP9—glaucoma	7.49e-05	0.00175	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—NGFR—glaucoma	7.36e-05	0.00172	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—VEGFA—glaucoma	7.28e-05	0.0017	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—MMP9—glaucoma	7.22e-05	0.00168	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—MMP9—glaucoma	7.16e-05	0.00167	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—MMP2—glaucoma	7.11e-05	0.00166	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—TGFB2—glaucoma	7.11e-05	0.00166	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—NTRK1—glaucoma	7e-05	0.00163	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—CTSA—glaucoma	6.9e-05	0.00161	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—MMP9—glaucoma	6.88e-05	0.0016	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—MMP9—glaucoma	6.88e-05	0.0016	CbGpPWpGaD
Rufinamide—CYP2E1—Biological oxidations—GSTM1—glaucoma	6.87e-05	0.0016	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—MMP2—glaucoma	6.8e-05	0.00159	CbGpPWpGaD
Rufinamide—CYP2E1—Metapathway biotransformation—GSTM1—glaucoma	6.78e-05	0.00158	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—VEGFA—glaucoma	6.72e-05	0.00157	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—MMP9—glaucoma	6.64e-05	0.00155	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—MMP9—glaucoma	6.64e-05	0.00155	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—MMP9—glaucoma	6.61e-05	0.00154	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—MMP2—glaucoma	6.53e-05	0.00152	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—MMP2—glaucoma	6.53e-05	0.00152	CbGpPWpGaD
Rufinamide—ALB—Metabolism—NARFL—glaucoma	6.5e-05	0.00151	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CA5A—glaucoma	6.5e-05	0.00151	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—VEGFA—glaucoma	6.49e-05	0.00151	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CDKN2B—glaucoma	6.45e-05	0.0015	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—TNF—glaucoma	6.44e-05	0.0015	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—VEGFA—glaucoma	6.43e-05	0.0015	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—MMP2—glaucoma	6.3e-05	0.00147	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—MMP2—glaucoma	6.3e-05	0.00147	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—TNF—glaucoma	6.24e-05	0.00145	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—MMP2—glaucoma	6.21e-05	0.00145	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—EDN1—glaucoma	6.19e-05	0.00144	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—VEGFA—glaucoma	6.18e-05	0.00144	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—VEGFA—glaucoma	6.18e-05	0.00144	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—VEGFA—glaucoma	5.96e-05	0.00139	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—VEGFA—glaucoma	5.96e-05	0.00139	CbGpPWpGaD
Rufinamide—ALB—Vitamin B12 Metabolism—TNF—glaucoma	5.94e-05	0.00139	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—VEGFA—glaucoma	5.93e-05	0.00138	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—PTGS2—glaucoma	5.69e-05	0.00133	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—NGF—glaucoma	5.69e-05	0.00133	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—TNF—glaucoma	5.56e-05	0.0013	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—C3—glaucoma	5.4e-05	0.00126	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—SOD1—glaucoma	5.39e-05	0.00126	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—MMP9—glaucoma	5.34e-05	0.00125	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—SLC6A13—glaucoma	5.32e-05	0.00124	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—MMP9—glaucoma	5.11e-05	0.00119	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—TNF—glaucoma	5.09e-05	0.00119	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—APOE—glaucoma	5.03e-05	0.00117	CbGpPWpGaD
Rufinamide—CYP3A4—Biological oxidations—GSTT1—glaucoma	5e-05	0.00117	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CAV1—glaucoma	4.99e-05	0.00116	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—MMP9—glaucoma	4.91e-05	0.00114	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—MMP9—glaucoma	4.91e-05	0.00114	CbGpPWpGaD
Rufinamide—ALB—Platelet degranulation—VEGFA—glaucoma	4.84e-05	0.00113	CbGpPWpGaD
Rufinamide—ALB—Folate Metabolism—TNF—glaucoma	4.84e-05	0.00113	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—VEGFA—glaucoma	4.8e-05	0.00112	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—FN1—glaucoma	4.75e-05	0.00111	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—MMP9—glaucoma	4.74e-05	0.0011	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—MMP9—glaucoma	4.74e-05	0.0011	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—BAD—glaucoma	4.69e-05	0.00109	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—MMP9—glaucoma	4.67e-05	0.00109	CbGpPWpGaD
Rufinamide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—glaucoma	4.61e-05	0.00107	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—VEGFA—glaucoma	4.59e-05	0.00107	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—MMP2—glaucoma	4.43e-05	0.00103	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—VEGFA—glaucoma	4.41e-05	0.00103	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—VEGFA—glaucoma	4.41e-05	0.00103	CbGpPWpGaD
Rufinamide—ALB—Folate Metabolism—TP53—glaucoma	4.26e-05	0.000994	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—VEGFA—glaucoma	4.25e-05	0.000991	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—VEGFA—glaucoma	4.25e-05	0.000991	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—VEGFA—glaucoma	4.19e-05	0.000976	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—TNF—glaucoma	4.11e-05	0.000959	CbGpPWpGaD
Rufinamide—CYP3A4—Biological oxidations—CYP1B1—glaucoma	3.99e-05	0.000929	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—TNF—glaucoma	3.93e-05	0.000917	CbGpPWpGaD
Rufinamide—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	3.93e-05	0.000917	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—SLC6A1—glaucoma	3.89e-05	0.000907	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—TNF—glaucoma	3.84e-05	0.000895	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—TNF—glaucoma	3.78e-05	0.000881	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—TNF—glaucoma	3.78e-05	0.000881	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—NOS3—glaucoma	3.77e-05	0.000879	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—FN1—glaucoma	3.75e-05	0.000874	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CA1—glaucoma	3.69e-05	0.000861	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—TGFB2—glaucoma	3.66e-05	0.000854	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—TNF—glaucoma	3.64e-05	0.000849	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—TNF—glaucoma	3.64e-05	0.000849	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CTSA—glaucoma	3.58e-05	0.000833	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CA5A—glaucoma	3.51e-05	0.000818	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—NARFL—glaucoma	3.51e-05	0.000818	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CA2—glaucoma	3.38e-05	0.000787	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—MMP9—glaucoma	3.33e-05	0.000776	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CDKN1B—glaucoma	3.27e-05	0.000761	CbGpPWpGaD
Rufinamide—CYP3A4—Biological oxidations—GSTM1—glaucoma	3.19e-05	0.000743	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CA1—glaucoma	3.17e-05	0.00074	CbGpPWpGaD
Rufinamide—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	3.14e-05	0.000733	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CTSA—glaucoma	3.07e-05	0.000716	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—MMP9—glaucoma	3.02e-05	0.000705	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—VEGFA—glaucoma	2.99e-05	0.000697	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CA2—glaucoma	2.9e-05	0.000676	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.84e-05	0.000661	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.84e-05	0.000661	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—SOD1—glaucoma	2.78e-05	0.000647	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—VEGFA—glaucoma	2.72e-05	0.000633	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—TNF—glaucoma	2.56e-05	0.000597	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—TXN—glaucoma	2.38e-05	0.000555	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—VEGFA—glaucoma	2.15e-05	0.0005	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—MMP1—glaucoma	2.12e-05	0.000494	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—TP53—glaucoma	2.05e-05	0.000478	CbGpPWpGaD
Rufinamide—ALB—Metabolism—TXN—glaucoma	2.04e-05	0.000477	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—CAV1—glaucoma	2.03e-05	0.000473	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—FN1—glaucoma	1.93e-05	0.00045	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.87e-05	0.000435	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.85e-05	0.000431	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GSTT1—glaucoma	1.84e-05	0.00043	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CA1—glaucoma	1.71e-05	0.000399	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CTSA—glaucoma	1.66e-05	0.000387	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GSTT1—glaucoma	1.59e-05	0.00037	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CA2—glaucoma	1.57e-05	0.000365	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—NOS3—glaucoma	1.54e-05	0.000358	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ABCA1—glaucoma	1.47e-05	0.000343	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CYP1B1—glaucoma	1.47e-05	0.000343	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.28e-05	0.000298	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYP1B1—glaucoma	1.26e-05	0.000294	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ABCA1—glaucoma	1.26e-05	0.000294	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GSTM1—glaucoma	1.18e-05	0.000274	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—VEGFA—glaucoma	1.11e-05	0.000258	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—TXN—glaucoma	1.1e-05	0.000257	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—MTHFR—glaucoma	1.04e-05	0.000242	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GSTM1—glaucoma	1.01e-05	0.000235	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—APOE—glaucoma	9.67e-06	0.000225	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CAV1—glaucoma	9.58e-06	0.000223	CbGpPWpGaD
Rufinamide—ALB—Metabolism—MTHFR—glaucoma	8.92e-06	0.000208	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GSTT1—glaucoma	8.56e-06	0.000199	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—TP53—glaucoma	8.36e-06	0.000195	CbGpPWpGaD
Rufinamide—ALB—Metabolism—APOE—glaucoma	8.31e-06	0.000194	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CAV1—glaucoma	8.23e-06	0.000192	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—NOS3—glaucoma	7.24e-06	0.000169	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ABCA1—glaucoma	6.82e-06	0.000159	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYP1B1—glaucoma	6.82e-06	0.000159	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PTGS2—glaucoma	6.62e-06	0.000154	CbGpPWpGaD
Rufinamide—ALB—Metabolism—NOS3—glaucoma	6.22e-06	0.000145	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PTGS2—glaucoma	5.69e-06	0.000133	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GSTM1—glaucoma	5.45e-06	0.000127	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—MTHFR—glaucoma	4.82e-06	0.000112	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—APOE—glaucoma	4.49e-06	0.000105	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CAV1—glaucoma	4.44e-06	0.000104	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—NOS3—glaucoma	3.36e-06	7.83e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PTGS2—glaucoma	3.07e-06	7.16e-05	CbGpPWpGaD
